本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

161.52
+7.094.59%
盘后160.92-0.6000-0.37%16:34 EDT
成交量:49.56万
成交额:7,907.69万
市值:97.52亿
市盈率:-25.66
高:162.30
开:155.20
低:154.64
收:154.43
数据加载中...
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/12

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities